Welcome to our dedicated page for Venu Holding SEC filings (Ticker: VENU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Venu Holding's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Venu Holding's regulatory disclosures and financial reporting.
Venu Holding Corp (VENU) director and CEO & Chairman Jay W. Roth reported a small open-market purchase of 49 shares of common stock on September 4, 2026 at $1.8811 per share. After this transaction, he holds 9,276,413 shares directly and is deemed to have indirect beneficial ownership of shares held by two family trusts.
Venu Holding Corp (VENU) director, officer, and ten percent owner Jay W. Roth reported purchasing 1,400 shares of common stock on September 2, 2026 in an open-market or private transaction at $1.8295 per share. Following this purchase, he holds 9,276,364 shares directly.
Roth is also deemed to have indirect beneficial ownership of additional shares held through two trusts: 62,500 shares held by the JWR Living Trust dated November 19, 2012 and 999,720 shares held by the KMR Living Trust dated November 19, 2012, where he serves as trustee. No Rule 10b5-1 trading plan is reported.
Venu Holding Corp (VENU) director, CEO & Chairman, and ten percent owner Jay W. Roth reported an open-market or private purchase of 2,100 shares of common stock on August 31, 2026 at $1.9048 per share, bringing his directly held stake to 9,274,964 shares. He also reports indirect beneficial ownership of 62,500 shares held by the JWR Living Trust and 999,720 shares held by the KMR Living Trust, where he serves as trustee. No Rule 10b5-1 trading plan is reported for this transaction.
Venu Holding Corp (VENU) reported that CEO, Chairman and 10% owner Jay W. Roth purchased 1,000 shares of common stock on 2026-08-27 at a price of $2.0168 per share in an open-market or private transaction. Following this purchase, he directly holds 9,272,864 shares of Venu common stock. In addition, he is deemed to have indirect beneficial ownership of shares held by the JWR Living Trust and the KMR Living Trust, where he serves as trustee.
Venu Holding Corp (VENU) director Thomas M. Finke reported an open-market purchase of common stock. On 2026-08-25, he purchased 54,644 shares of common stock at a price of $1.949 per share. Following this transaction, he directly owns 129,605 shares of Venu Holding Corp common stock.
Venu Holding Corp (VENU) reported that CEO, Chairman and ten percent owner Jay W. Roth purchased 1,000 shares of common stock on 2026-08-25 in an open-market or private transaction at $1.8978 per share. Following this purchase, he holds 9,271,864 shares of common stock directly.
In addition, the filing reports indirect holdings of 62,500 shares held by the JWR Living Trust dated November 19, 2012 and 999,720 shares held by the KMR Living Trust dated November 19, 2012, where Mr. Roth is a trustee and is deemed to have indirect beneficial ownership. The Rule 10b5-1 trading plan checkbox was not marked as applicable.
Venu Holding Corp (VENU) director Thomas M. Finke reported an open-market or private purchase of 30,000 shares of common stock on 2026-08-21 at $1.92 per share. Following this transaction, he directly holds 74,961 shares of VENU common stock. The filing indicates the Rule 10b5-1 trading-plan box was not checked.
Venu Holding Corp (VENU) insider Jay W. Roth, the CEO, Chairman and a more-than-10% owner, purchased 1,000 shares of common stock on August 21, 2026 at $1.9176 per share in an open-market or private transaction. Following this trade, he holds 9,270,864 shares directly. In addition, he is deemed to have indirect beneficial ownership of 62,500 shares held by the JWR Living Trust dated November 19, 2012 and 999,720 shares held by the KMR Living Trust dated November 19, 2012, where he serves as trustee.
Venu Holding Corp (VENU) reported that CEO, Chairman and 10% owner Jay W. Roth purchased 1,000 shares of common stock on 2026-08-19 at $1.8852 per share in an open-market or private transaction. Following this trade, he directly holds 9,269,864 shares. He is also deemed to have indirect beneficial ownership of 62,500 shares held by the JWR Living Trust and 999,720 shares held by the KMR Living Trust, where he serves as trustee.
Venu Holding Corp (VENU) is calling a virtual annual shareholder meeting on September 23, 2026 to vote on director elections and several capital-structure items. Shareholders of record on July 27, 2026, when 58,869,339 common shares were outstanding, are entitled to one vote per share.
Key business items include: electing seven directors; approving, under NYSE American Section 713, the potential issuance of 20% or more of the July 31, 2026 outstanding shares tied to a July 2026 debt financing with YA II PN, Ltd.; increasing the share reserve under the 2023 Omnibus Incentive Compensation Plan from 7,500,000 to 10,000,000 shares; and ratifying Grassi & Co., CPAs, P.C. as auditor for 2026.
The July 2026 financing comprises $25,000,000 of Senior Secured Convertible Debentures (fixed conversion price $7.50 per share, with default-driven variable pricing down to a $0.448 floor) and Warrants for 1,200,000 shares at exercise prices of $5.00 and $6.25. NYSE rules cap issuance at 11,767,980 shares (19.99% of shares outstanding on the issuance date) unless shareholders approve a higher amount, which the Board recommends.